MedTrace Logo

A Comparison of Beclomethasone Aqueous Spray and Aerosol Delivery Systems in Nasal Polyps

NCT00788463 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2017-08-28

No results posted yet for this study

Summary

The purpose of this study is to determine if intranasal Beclomethasone delivered by aerosol or spray is more effective in treatment of nasal polyps.

Conditions

  • Nasal Polyps

Interventions

DRUG

Intranasal Beclomethasone aerosol

Beclomethasone aerosol intranasal, 100ug each nostril, twice daily for 6 months.

DRUG

Intranasal Beclomethasone spray

Beclomethasone spray intranasal, 100ug each nostril, twice daily for 6 months.

Sponsors & Collaborators

  • London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

    lead OTHER

Principal Investigators

  • Jorge A Mazza, MD · Western University, Canada

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-23
Primary Completion
2009-03-30
Completion
2011-11-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00788463 on ClinicalTrials.gov